← Back to Clinical Trials
Recruiting NCT05698810

NCT05698810 Preparation and Feasibility of Exams for Expected Studies

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05698810
Status Recruiting
Phase
Sponsor University Hospital, Grenoble
Condition Healthy Volunteers
Study Type INTERVENTIONAL
Enrollment 150 participants
Start Date 2023-03-20
Primary Completion 2033-03-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
CE marked Medical Device MagnetoEncephaloGraphy (MEG) usabilityCE marked Medical Device Magnetic Resonance Imaging (MRI) usabilityCE marked Medical Device ElectroEncephaloGraphy (EEG) usability

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 150 participants in total. It began in 2023-03-20 with a primary completion date of 2033-03-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Feasibility study: the examinations carried out as part of this protocol aim to carry out all the acquisitions and simulations of use, necessary for the development of the clinical research protocols to come to Clinatec (in particular, configuration of the equipment, dimension of the examination time and the size of the cohorts etc ...)

Eligibility Criteria

Inclusion Criteria: * Age ⩾ 18 years * Affiliated to a social security scheme * Free and informed consent signed Exclusion Criteria: * Subject in a period of exclusion from another study. * Subject deprived of liberty by a judicial or administrative decision, or major subject subject to a legal protection measure (guardianship, curatorship and safeguarding of justice) referred to in Articles 1121-6 to 1121-8 of the Public Health Code. * Subject who would receive more than 4500 euros in compensation because of his participation in other research involving the human person in the 12 months preceding this study. * Pregnant woman, parturient, nursing mother (Article 1121-5 of the Public Health Code) * Subject not reachable urgently.

Frequently Asked Questions

Who can join the NCT05698810 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy Volunteers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05698810 currently recruiting?

Yes, NCT05698810 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital, Grenoble to inquire about joining.

Where is the NCT05698810 trial being conducted?

This trial is being conducted at Grenoble, France.

Who is sponsoring the NCT05698810 clinical trial?

NCT05698810 is sponsored by University Hospital, Grenoble. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology